Patent directory · USPTO A61K / A61P
Patents matching “Neurocrine Biosciences, Inc.”
110 pharma patents match "Neurocrine Biosciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 110 pharmaceutical patents matching "Neurocrine Biosciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12421193
GPR52 modulators and methods of use
granted -
US 12383536
CRF receptor antagonists and methods of use
granted -
US 12128033
Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine
granted -
US 12102637
Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
granted -
US 12083227
Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
granted -
US 11730739
Treatment of congenital adrenal hyperplasia
granted -
US 11718618
Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors
granted -
US 11713324
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
granted -
US 11654142
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11459305
Processes for the preparation of uracil derivatives
granted -
US 11439629
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11311532
High dosage valbenazine formulation and compositions, methods, and kits related thereto
granted -
US 11311544
Treatment of congenital adrenal hyperplasia
granted -
US 11053242
[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11BH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto
granted -
US 11040029
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11040970
VMAT2 inhibitor compounds and compositions thereof
granted -
US 11033539
Compounds of formulas (VII), (VIII), (IX), (XI), (XII), (XIII), and (XIV) as muscarinic receptor 4(M4) antagonists for treating neurological diseases
granted -
US 11026931
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11026939
High dosage valbenazine formulation and compositions, methods, and kits related thereto
granted -
US 11021449
Substituted triazoles and methods relating thereto
granted -
US 10993941
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10952997
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10941159
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
granted -
US 10940141
Methods for the administration of certain VMAT2 inhibitors
granted